MetLife stock: buy or sell?

MET stock price: $47.44 -0.88% At close on September 20th, 2019

Updated on:
September 20th, 2019

4

MetLife slightly fell an unpleasant -0.88% and closed at $47.44.

MetLife, Inc., through its subsidiaries, provides life insurance, annuities, employee benefits, and asset management products in the United States, Japan, Latin America, Asia, Europe, and the Middle East.

Should I buy MetLife stock?

Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. That's why is so important to choose your own trading plan that matches with your character as inversor. At Stocks2.com, we use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.

Currently, MetLife stock doesn't match any of these trading strategies, so our recommendation is not to buy.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This is not a selling recommendation at all, just it's not the best moment to buy if you follow any of these trading strategies.

Is MetLife stock a buy?

Everyday, hundreds of stock ratings are posted by financial analysts to indicate a particular stock's attractiveness. At Stocks2.com, we detected 12 ratings published for MET stock in the last 30 days.

Is MET a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-9-13Citigroupn/aSell
2019-8-20Morgan Stanleyn/aEqual Weight
2019-7-11Wells Fargo & Con/aOutperform
2019-5-23Citigroupn/aSell
2019-5-22Barclaysn/aOverweight
2019-4-9UBS GroupNeutralHold
2019-4-12Deutsche Bankn/aHold
2019-3-19Sandler O'NeillBuyHold
2019-2-12Argusn/aBuy
2019-1-8Wells Fargo & Con/aBuy
2019-1-2Sandler O'NeillHoldBuy
2019-1-16Bank of AmericaNeutralBuy

MetLife stock analysis

Daily outlook

Shares of MetLife ended today at $47.44 and slightly fell an unpleasant -0.88%.

Shares of MetLife closed today at $47.44 and slightly fell an unpleasant -0.88%. Since price and SMA200d lines crossed up on September/5, MET climbed $2.95 (6.63%). Since May when SMA100d and SMA200d crossed up, MET price gained $0.40 per share (0.85%).

MET stock chart (daily)

Weekly outlook

MetLife shares depreciated -1.92% this week, ending at $47.44. Late July MET plunged a frightening -7.19% in just one week.

The downtrend marked by MET has left consecutive declining peaks and bottoms. There is a chance to rebound and reverse this situation if price can hold above the level. Early September MET price bounced up over the SMA of 40 weeks that acted as support stopping new slides. Since late April when SMA20w and SMA40w crossed up, MET price gained $3.17 per share (7.16%).

MET stock chart (weekly)

MetLife stock price history

MetLife stock went public on April 5th, 2000 with a price of $8.461. Since then, MET stock surged a 460.80%, with an average of 24.30% per year. If you had invested right after MET's IPO a $1,000 in MetLife stock in 2000, it would worth $4,608.00 today.

1: Adjusted price after possible price splits or reverse-splits.

MetLife stock historical price chart

MET stock reached 52-week highs on August at $50.68, and all-time highs 2017-11-02 with a price of 52.05.

MetLife stock price target is $49.00

How much a stock will be priced tomorrow or next week is quite unpredictable However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. For the last 30 days we found 7 price targets for MET stock:
MET stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-9-13CitigroupLowers Target$42.00$41.00-2.4%
2019-8-20Morgan StanleyLowers Target$54.00$53.00-1.9%
2019-7-11Wells Fargo & CoRaises Target$55.00$57.003.6%
2019-5-23CitigroupSet Price Targetn/a$42.00-
2019-5-22BarclaysRaises Target$52.00$55.005.8%
2019-4-9UBS GroupReiterates$45.00$48.006.7%
2019-4-12Deutsche BankRaises Target$46.00$47.002.2%
(in average)$49.00$49.000.0%
The price prediction for MetLife stock is $49.00, moving in a range between $57.00 and $41.00. In average, analysts' outlook on MET price forecast is stable from previous estimations.

Financials and fundamental analysis

Earnings date and Earnings per Share

Since April, when MetLife posted its last earnings report, it . As soon as we get its actual EPS from the earnings report, we will update this report.
MET earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2017-Q2-n/a1.5n/a
2017-Q32017-11-010.91.0921.1%
2017-Q42018-02-130.640.640.0%
2018-Q12018-05-021.171.3616.2%
2018-Q22018-08-011.171.311.1%
2018-Q32018-11-011.251.3810.4%
2018-Q42019-02-061.31.353.8%
2019-Q12019-04-301.28n/an/a
2019-Q2-n/an/an/a
2019-Q3-n/an/an/a

Annual financial results

In 2018, MetLife annual turnover soared an impressive 9.04% to $67,941.00 million dollars from $62,308.00 marked in 2017. Nonetheless, its income margin (compared to sales) stepped up to 7.54%, that is $5,123.00 million.

MetLife presents anual results in December, and to compare its evolution since then, we estimate annual sales and income figures by adding results from the last 4 quarters. This is called TTM (or Twelve Trailing Months). So, MetLife TTM sales up to March 2019 were $69,438.00 and income $5,251.00 million dollars. If we compare this TTM figures with the last reported annuality, we can esteem MetLife business evolution since December 2018: Annual revenues up to March, compared to lastest yearly report, inched a slightly fine 2.20%. Nevertheless, profit margin (net income/revenues) remained stable at 7.54%.

MET annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY
2013$70,760 M-$3,370 M4.8%-
2014$73,316 M3.61%$6,309 M8.6%87.21%
2015$69,951 M-4.59%$5,310 M7.6%-15.83%
2016$63,476 M-9.26%$800 M1.3%-84.93%
2017$62,308 M-1.84%$4,010 M6.4%401.25%
2018$67,941 M9.04%$5,123 M7.5%27.76%
TTM $69,438 M2.20%$5,251 M7.6%2.50%

Quarterly financial results

MetLife reported $16,302.00 million in sales for 2019-Q1, a 4.09% up compared to previous quarter. Reported quarter earnings marked $1,381.00 M with a profit margin of 8.47%. Profit margin decreased a -4.73% compared to previous quarter when profit margin was 13.20%. When comparing turnover to same quarter last year, MetLife sales marked a great gain and skyrocketed a 10.11%.
MET quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2
2017-Q2$17,780 M-$884 M5.0%-
2017-Q3$16,104 M-9.43%$-81 M-0.5%-109.16%
2017-Q4$15,840 M-1.64%$2,317 M14.6%-2,960.49%
2018-Q1$14,805 M-6.53%$1,253 M8.5%-45.92%
2018-Q2$21,185 M43.09%$891 M4.2%-28.89%
2018-Q3$16,289 M-23.11%$912 M5.6%2.36%
2018-Q4$15,662 M-3.85%$2,067 M13.2%126.64%
2019-Q1$16,302 M4.09%$1,381 M8.5%-33.19%

MetLife ownership

When you are planning to invest in shares of a stock, it's worth to overview its ownership structure.

MetLife shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 61.88% of all shares.

In case of MetLife stock, 0.00% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for MET stock account 0.00%, no big difference from last month.

The following table compares ownership indicators for other stocks related to MetLife:

METAEGAFGAIZCNO
Market cap$44.4 B$8.5 B$9.8 B$7.7 B$2.5 B
Total shares936.5 M2,010.0 M89.9 M61.1 M156.0 M
Float shares791.1 M1,730.0 M72.1 M60.4 M154.0 M
  - Institutional holdings (%)0.0%8.1%67.1%86.1%97.4%
  - Insider holdings (%)61.9%0.0%17.6%1.0%1.1%
Shares in short selling0.0%0.0%0.0%0.0%0.0%

MetLife summary

Friday, September 20th, 2019
Open$48.02
Close$47.44
Day range$47.23 - $48.02
Previous close$47.86
Session gain-0.88%
Average true range$1.01
50d mov avg$47.13
100d mov avg$47.50
200d mov avg$45.08
Daily patternlt01a
Weekly pattern lt02a

MetLife performance

Performance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. In the following table, we compare MetLife to Aegon, American Financial, Assurant, CNO Financial, Horace Mann Educators, Prudential Public and Voya Financial:
Stock3m6m12m
METMetLife-2.08%15.65%0.96%
AEGAegon-8.21%-4.92%-29.28%
AFGAmerican Financia...5.93%17.43%0.25%
AIZAssurant18.67%34.95%22.79%
CNOCNO Financial-2.14%3.03%-25.13%
HMNHorace Mann Educa...10.85%33.68%1.02%
PUKPrudential Public-14.20%-7.99%-20.13%
VOYAVoya Financial1.58%13.64%8.79%

MetLife competitors

We picked a few stocks to conform a list of MetLife competitors to check if you are interested in investing in MET:

Latest MetLife stock news